Neurocrine Biosciences Retained Earnings Quarterly YoY Growth
Neurocrine Biosciences Historical Retained Earnings Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
About Retained Earnings Growth
Retained Earnings Growth is the percent increase/decrease of a company's retained net income over time. A company can use retained earnings to maintain current operations, or to invest in new ventures. Generally speaking, retained earnings growth is accompanied by subsequent increases in sales and profitability.
If a company's retained earnings at the end of 2008 were $12 million, and by the end of 2009 the company's retained earnings increased to $15 million, the company experienced a retained earnings growth of 25%.
Learn More
NBIX Retained Earnings Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Ariad Pharmaceuticals | |
| Array BioPharma | |
| Celldex Therapeutics |
